Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms


Peritoneal topics
Peritoneal Dialysis
Peritoneal Cavity
Dialysis System
Abdominal Cavity
Wireless Communication Device
Hydrogen Sulfide
Ultraviolet Light

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents


Peritoneal patents

This page is updated frequently with new Peritoneal-related patent applications. Subscribe to the Peritoneal RSS feed to automatically get the update: related Peritoneal RSS feeds. RSS updates for this page: Peritoneal RSS RSS

User wearable device for carrying peritoneal dialysis catheter

User wearable device for carrying peritoneal dialysis catheter

Date/App# patent app List of recent Peritoneal-related patents
 Exterior cap of transfer set for peritoneal dialysis patent thumbnailExterior cap of transfer set for peritoneal dialysis
An exterior cap of transfer set for peritoneal dialysis, including: a cylindrical cap unit to which the end connector of the peritoneal transfer set is coupled; a guide unit that is coupled to the cap unit, extends to the peritoneal transfer set to provide an expanding internal space, and guides the end connector of the peritoneal transfer set into the cap unit; and a coupling-separating unit that combines the cap unit and the guide unit with each other and separates the cap unit and the guide unit in accordance with selection of a user.. .
Research Cooperation Foundation Of Yeungnam University
 Dipeptide mimetics of ngf and bdnf neurotrophins patent thumbnailDipeptide mimetics of ngf and bdnf neurotrophins
The invention relates to compounds having either agonist or antagonist activities for the neurotrophins ngf and bdnf and represented by monomeric or dimeric substituted dipeptides that are analogs of the exposed portions of loop 1 or loop 4 regions of these neurotrophins near or at a beta-turn of the respective loop. N-acylated substituents of these dipeptides are biostereoisomers of the amino acid residues preceding these dipeptide sequences in the neurotrophin primary structure.
Uchrezhdenie Rossiiskoi Akademii Meditsynskikh Nauk Nauchno-issledovatelsky Institut Farmakologii
 User wearable device for carrying peritoneal dialysis catheter patent thumbnailUser wearable device for carrying peritoneal dialysis catheter
Improvements in an easily wearable catheter. A housing secures the components of the catheter, i.e.
 Line leaf inula flower lactone a and methods for preparing and using the same for treating myocarditis patent thumbnailLine leaf inula flower lactone a and methods for preparing and using the same for treating myocarditis
The compound shows positive therapeutic activity against coxsackie virus and significant dose dependent correlation. The line leaf inula flower lactone a prevents disease in mouse models of experimental autoimmune myocarditis and onset of the process by intraperitoneal injection of a dose of 20 mg/kg/d.
 Compounds as rearranged during transfection (ret) inhibitors patent thumbnailCompounds as rearranged during transfection (ret) inhibitors
This invention relates to novel compounds which are inhibitors of the rearranged during transfection (ret) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of gastrointestinal sensitivity, motility and/or secretion and/or abdominal disorders or diseases and/or treatment related to diseases related to ret dysfunction or where modulation of ret activity may have therapeutic benefit including but not limited to all classifications of irritable bowel syndrome (ibs) including diarrhea-predominant, constipation-predominant or alternating stool pattern, functional bloating, functional constipation, functional diarrhea, unspecified functional bowel disorder, functional abdominal pain syndrome, chronic idiopathic constipation, functional esophageal disorders, functional gastroduodenal disorders, functional anorectal pain, inflammatory bowel disease, proliferative diseases such as non-small cell lung cancer, hepatocellular carcinoma, colorectal cancer, medullary thyroid cancer, follicular thyroid cancer, anaplastic thyroid cancer, papillary thyroid cancer, brain tumors, peritoneal cavity cancer, solid tumors, other lung cancer, head and neck cancer, gliomas, neuroblastomas, von hippel-lindau syndrome and kidney tumors, breast cancer, fallopian tube cancer, ovarian cancer, transitional cell cancer, prostate cancer, cancer of the esophagus and gastroesophageal junction, biliary cancer, adenocarcinoma, and any malignancy with increased ret kinase activity.. .
Glaxosmithkline Intellectual Property Development Limited
 Method and  performing retro peritoneal dissection patent thumbnailMethod and performing retro peritoneal dissection
Cmos or ccd camera device. According to one embodiment, fiber optics run semi-circumferentially or along walls of the cannula/dilator and terminate at about a centimeter from the distal end of the cannula/dilator, thereby preventing illumination from “bottoming out” at the floor of the incision.
 Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy patent thumbnailMethods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
Methods and compositions for reducing, preventing or reducing the progression of calcification in peritoneal dialysis patients are provided. In an embodiment, the present disclosure provides a method comprising administering to a patient during peritoneal dialysis therapy a dialysis solution comprising a therapeutically effective amount of pyrophosphate ranging between about 30 μm and about 400 μm.
Baxter International Inc.
 Automated peritoneal dialysis system using stepper motor patent thumbnailAutomated peritoneal dialysis system using stepper motor
An embodiment of a peritoneal dialysis system includes an enclosure, a door hingedly attached to the enclosure, a stepper motor housed by the enclosure, a solid pump piston in operable communication with the stepper motor and including a solid pump shaft attached to or integrally formed with a solid pump head, and a disposable unit contacting the enclosure and the door. The disposable unit includes a moveable membrane operable with the solid pump head.
Baxter Healthcare S.a.
 Systems with disposable pumping unit patent thumbnailSystems with disposable pumping unit
An embodiment of a peritoneal dialysis system includes a peritoneal dialysis hardware unit having a housing with a first opening, a door coupled to the housing and having a second opening, and a solid pump piston having a solid piston shaft attached to or integrally formed with a solid piston head. The system also includes a stepper motor operable to cause the solid pump piston to translate; a disposable pumping unit having a first and a second opposing surface, and a fluid pump receptacle extending from the first and second surface to fit within the second opening.
Baxter Healthcare S.a.
 Nitrogenous heterocyclic derivatives and their application in drugs patent thumbnailNitrogenous heterocyclic derivatives and their application in drugs
The present invention relates to the field of medicine, provided herein are novel nitrogenous heterocyclic compounds, their preparation methods and their uses as drugs, especially for treatment and prevention of tissue fibrosis. Also provided herein are pharmaceutically acceptable compositions comprising the nitrogenous heterocyclic compounds and the uses of the compositions in the treatment of human or animal tissue fibrosis, especially for human or animal renal interstitial fibrosis, glomerular sclerosis, liver fibrosis, pulmonary fibrosis, peritoneal fibrosis, myocardial fibrosis, dermatofibrosis, postsurgical adhesion, benign prostatic hyperplasia, skeletal muscle fibrosis, scleroderma, multiple sclerosis, pancreatic fibrosis, cirrhosis, myosarcoma, neurofibroma, pulmonary interstitial fibrosis, diabetic nephropathy, alzheimer disease or vascular fibrosis..
Sunshine Lake Pharma Co., Ltd.

Dye conjugated peptides for fluorescent imaging

The present application discloses compositions and methods of use of peptide targetable constructs for detection, diagnosis and/or imaging of cancer. In preferred embodiments, the targetable construct comprises at least one hapten, at least one fluorescent probe, a chelating moiety and a group iiia metal-18f complex attached to the chelating moiety.
Immunomedics, Inc.

Peritoneal dialysis machine

A method for operating a dialysis cassette including a flexible membrane that covers a pump chamber includes allowing a source of fluid to fluidly communicate with the pump chamber of the dialysis cassette, filling the pump chamber with the fluid from the source, mechanically extending the flexible membrane into the pump chamber with a piston head to expel the fluid from the pump chamber through a flow path, and directly sensing a pressure of the fluid flowing through the flow path at a location of the dialysis cassette adjacent to the pump chamber and using the sensed pressure to perform a test prior to delivering fluid to a patient.. .
Baxter Healthcare S.a.

Medicament, method, and drug delivery device for treatment of ovarian cancer

Drug delivery devices, medicaments, and methods are provided for the intraperitoneal treatment of ovarian cancer. An implantable device for drug delivery includes an elongated, flexible device having a housing defining a reservoir that contains a drug in solid or semi-solid form, and configured to be wholly deployed within the peritoneal cavity of a patient and continuously release a therapeutically effective amount of the drug over a period of at least 24 hours.
The General Hospital Corporation

Methods and compositions for treating recurrent cancer

The present invention provides methods of treating recurrent cancer (such as recurrent ovarian, peritoneal, or fallopian tube cancer) in an individual, comprising administering to the individual an effective amount of a composition (such as nab-paclitaxel or abraxane®) comprising nanoparticles comprising a taxane and a carrier protein.. .
Abraxis Bioscience, Llc

Compositions for improved tissue oxygenation by peritoneal ventilation

Compositions and methods for improving transperitoneal oxygen uptake during peritoneal ventilation for extrapulmonary oxygenation of an organism or individual organs in preferably life-threatening case of need, such as pulmonary failure or circulatory shock, are disclosed. Such deficiencies can be addressed by transperitoneal administration of oxygen via a gas introduced into the abdominal cavity.
Sangui Biotech International, Inc.

System and administering peritoneal dialysis

Systems and methods are provided for improved techniques associated with administering peritoneal dialysis. Embodiments of the invention relate to the continuous introduction and circulation of dialysate fluid in and through the peritoneal cavity.

Apparatus and ovarian cancer screening

An apparatus and method are provided for sampling the distal tube, fimbria and/or ovary, includes advancing a device into the peritoneal cavity and sampling material on or adjacent to the distal tube, fimbria or ovary.. .
Mkt Enterprises, Llc

Drug elution for in vivo protection of bio-sensing analytes

A sensor (e.g., an optical sensor) that may be implanted within a living animal (e.g., a human) and may be used to measure an analyte (e.g., glucose or oxygen) in a medium (e.g., interstitial fluid, blood, or intraperitoneal fluid) within the animal. The sensor may include a sensor housing, an analyte indicator covering at least a portion of the sensor housing, and one or more therapeutic agents.
Senseonics, Incorporated

Fluid pumping systems, devices and methods

Embodiments of the present invention relate generally to certain types of reciprocating positive-displacement pumps (which may be referred to hereinafter as “pods,” “pump pods,” or “pod pumps”) used to pump fluids, such as a biological fluid (e.g., blood or peritoneal fluid), a therapeutic fluid (e.g., a medication solution), or a surfactant fluid. The pumps may be configured specifically to impart low shear forces and low turbulence on the fluid as the fluid is pumped from an inlet to an outlet.
Deka Products Limited Partnership

Self-warming peritoneal dialysis solution bag

A self-warming peritoneal dialysis solution bag is provided that contains a peritoneal dialysis solution. The solution bag can have an outer surface and a non-electric, warming patch adhered or affixed to the outer surface.
Fresenius Medical Care Holdings, Inc.

Molluscum contagiosum viral fusion protein treatment for atopic dermatitis diseases

Compositions, methods, and kits are provided for treating ccr8 mediated diseases with applicability to atopic dermatitis and potential applicability to asthma, prurigo nodularis, nummular dermatitis, neurodermatitis, and lichen simplex chronicus and some lymphomas, multiple sclerosis, acquired immunodeficiency disease, peritoneal adhesions, kaposi's sarcoma and atherogenesis—the expression of all of which, at least in part, is mediated by cells expressing the chemokine receptor ccr8. The compositions include proteins and fusion proteins from molluscum contagiosum virus (mcv) or variants, analogs and derivatives thereof which exhibit inhibitory activity.

Method of mending a groin defect

A method of mending a groinal defect such as an indirect inguinal hernia, a direct inguinal hernia, and/or a femoral hernia. A space between the external oblique aponeurosis and the internal oblique aponeurosis is dissected superiorly and laterally to create a site for receiving a lateral portion of a prosthetic repair patch.
Bard Shannon Limited

Transperitoneal prolapse repair system and method

A prolapse repair system and procedure are provided. The system can include one or more anchor devices and one or more extending members, such as a suture.

Hemodialysis and peritoneal dialysis systems having electrodeionization capabilities

Systems and methods for hemodialysis or peritoneal dialysis having integrated electrodeionization capabilities are provided. In an embodiment, the dialysis system includes a carbon source, a urease source and an electrodeionization unit.
Emd Millipore Corporation

Methods and devices for the diagnosis and treatment of diabetes

Methods and devices for the diagnosis and treatment of diabetes are disclosed in which an analyte concentration within a peritoneal fluid of a human subject may be determined by implanting an analyte sensor apparatus in the subject where the apparatus may comprise a housing and a flexible sensing catheter which has a lumen with a plurality of apertures and an exterior surface with an analyte sensor affixed thereto. The catheter may comprise a proximal end attached to the housing and the remaining end may be positioned freely within the peritoneal space to contact peritoneal fluid where an analyte concentration in the peritoneal fluid may be sensed.
Theranova, Llc

Apparatus and reducing the occurrence of post-surgical adhesions

A method for inhibiting formation of adhesions following abdominal surgery which involves application of an anti-static fatty acid ethoxylated amide (cocamide dea) in a matrix that is placed in the peritoneal cavity at the conclusion of an abdominal surgery and which releases this anti-adhesive chemical over a predetermined time in a range up to seven days. Tests conducted on laboratory rats established that the method reduced the incidence of adhesions from 100 percent (100%) in a test model to near zero in the majority of treated animals.
Anhese Llc

Peritoneal dialysis systems, devices, and methods

An automated peritoneal dialysis system provides various features including prescription-driven dialysis fluid preparation, an integrated disposable fluid circuit, and sensor capabilities that allow accurate filing and draining control with high safety margins. Features include a peritoneal fluid circuit with a pressure sensor at either end and methods and devices for using the pressure signals.
Nxstage Medical, Inc.

Peritoneal dialysis fluid comprising a gsk-3 inhibitor

The present invention relates to a peritoneal dialysis fluid comprising a compound inhibiting glycogen synthase kinase (gsk)-3 activity, in particular (gsk)-3β activity, for use in the prevention of infectious and non-infectious peritoneal complications such as peritonitis, peritoneal membrane injury, damage and failure, barrier dysfunction and mesothelial cell detachment.. .
Zytoprotec Gmbh

Enzyme replacement therapy for treating mps vii related bone lesions using a chemically modified enzyme

The invention relates to a method of treating mucopolysaccharidoses using enzyme replacement therapy with chemically modified lysosomal enzymes. More specifically the method relates to administering chemically modified lysosomal enzymes intraperitoneal injection.
Carol Ann Foundation And International Morquio Organization

Laparoscopic trocar with ventriculoperitoneal shunt entry port

An example laparoscopic trocar assembly can be used for insertion of a ventriculoperitoneal (“vp”) shunt into an abdomen and comprises an optical system a trocar sleeve to allow a surgeon to see abdominal tissue being punctured and see into an abdominal cavity. An example trocar assembly comprises an entry port in the trocar's side and a stylet to insert a vp shunt tube into an abdomen.

Hernia repair device with core and advanced pre-peritoneal disk deployment

An implant to repair a hole in a muscle wall includes a flat mesh with a central resilient core which deforms to place the core in a hole in a muscle wall and then resiliently expands when released to urge against the perimeter of the hole, dynamically “riding” in the hole as the hole perimeter expands and contracts. Straps on the mesh are tunneled through tissue in the muscle wall containing the hole to hold the mesh with core in place..

Peritoneal dialysis systems and methods that regenerate dialysate

A method for providing a peritoneal dialysis treatment that regenerates therapy fluid includes coupling a single fluid circuit having a cleaning cartridge to a peritoneal cavity of a patient, feeding a first amount of therapy fluid into the single fluid circuit, circulating the first amount of therapy fluid multiple times through the single fluid circuit and the peritoneal cavity of the patient, removing a therapeutically effective amount of solutes and ultrafiltrate from the patient using the first amount of therapy fluid, cleaning the first amount of therapy fluid using the cleaning cartridge, removing an amount of fluid from the single fluid circuit, the amount of fluid including at least most of the removed solutes, and feeding a second amount of therapy fluid into the single fluid circuit, the second amount of therapy fluid being approximately equal to the amount of fluid removed from the fluid circuit.. .

Hernia model

A model for practicing transabdominal pre-peritoneal (tapp) and total extraperitoneal (tep) approaches for laparoscopic hernia repairs is provided. The model simulates an insufflated space between the abdominal muscles and peritoneum.

Intrauterine fetal growth restriction - the biochemical rationale of treatment modalities including extraperitoneal transamniotic fetal supplements

Intrauterine fetal growth restriction (iugr) is an affliction of a disparaging spectrum, placental insufficiency being the major inciting pathology. The resultant fetal hypoglycemia is alleviated by intravenous hypertonic d-glucose 25-50% maternal supplements, by improving the vmax of placental transfer for d-glucose, in accordance with michaelis-menten model of substrate transfer.

Medical treatment system and methods using a plurality of fluid lines

A medical treatment system, such as peritoneal dialysis system, may include control and other features to enhance patient comfort and ease of use. For example, a peritoneal dialysis system may include patient line state detector for detecting whether a patient line is primed before it is to be connected to the patient.

Isoxazole compound for the treatment of cancer

The use of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide or a tautomer thereof or a pharmaceutically acceptable salt or a hydrate or a solvate for the treatment of cancer of the bladder, the colon, the liver, the lung, the breast, the vagina, the ovaries, the pancreas, the kidney, the stomach, the gastrointestinal tract, the prostate, the head and neck, the peritoneal cavity, the thyroid, the bone, the brain, the central nervous system and/or the blood and/or for the treatment of myelodysplastic syndrome, systemic mastocytosis, von hippel-lindau syndrome, multicentric castleman disease and/or psioriasis.. .

Popular terms: [SEARCH]

Peritoneal topics: Peritoneal, Peritoneal Dialysis, Peritoneal Cavity, Dialysis System, Intraperitoneal, Abdominal Cavity, Hemodialysis, Anastomosis, Wireless Communication Device, Colorectal, Hydrogen Sulfide, Sulfonamide, Ultraviolet, Ultraviolet Light, Subcutaneous

Follow us on Twitter
twitter icon@FreshPatents


This listing is a sample listing of patent applications related to Peritoneal for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Peritoneal with additional patents listed. Browse our RSS directory or Search for other possible listings.



2 - 1 - 73